153 related articles for article (PubMed ID: 34988293)
1. Role of neutrophil to lymphocyte ratio as a prognostic indicator for COVID-19.
Amer SA; Albeladi OA; Elshabrawy AM; Alsharief NH; Alnakhli FM; Almugathaui AF; Almashahadi SS; Dawood HM; Malik MB; Shah J; Aiash H
Health Sci Rep; 2021 Dec; 4(4):e442. PubMed ID: 34988293
[TBL] [Abstract][Full Text] [Related]
2. The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia: A case-control retrospective multicenter study.
Sayed AA; Allam AA; Sayed AI; Alraey MA; Joseph MV
Saudi Med J; 2021 Apr; 42(4):370-376. PubMed ID: 33795491
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
5. Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.
Bhandari S; Singh A; Sharma R; Rankawat G; Banerjee S; Gupta V; Dube A; Kakkar S; Sharma S; Keswani P; Agrawal A; Tak A; Nawal CL
J Assoc Physicians India; 2020 Jun; 68(6):13-19. PubMed ID: 32610873
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-to-Lymphocyte Ratio as a Predictor of Disease Severity and Mortality in Coronavirus Disease 2019: Prospective Study From Central India.
Rathod BD; Amle D; Khot RS; Prathipati KK; Joshi PP
Cureus; 2022 Mar; 14(3):e23696. PubMed ID: 35519791
[TBL] [Abstract][Full Text] [Related]
7. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological and initial clinical characteristics of patients with family aggregation of COVID-19.
Xia XY; Wu J; Liu HL; Xia H; Jia B; Huang WX
J Clin Virol; 2020 Jun; 127():104360. PubMed ID: 32305025
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil to lymphocyte ratio (NLR) in COVID-19: A cheap prognostic marker in a resource constraint setting.
Toori KU; Qureshi MA; Chaudhry A; Safdar MF
Pak J Med Sci; 2021; 37(5):1435-1439. PubMed ID: 34475926
[TBL] [Abstract][Full Text] [Related]
10. Utility of Neutrophil-Lymphocyte Ratio (NLR) as an Indicator of Disease Severity and Prognostic Marker among Patients with Covid-19 Infection in a Tertiary Care Centre in Bangalore - A Retrospective Study.
PrakashRao VV
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443517
[TBL] [Abstract][Full Text] [Related]
11. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
Khan M; Khan H; Khan S; Nawaz M
J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
[No Abstract] [Full Text] [Related]
13. Dynamic Profile of Prognostic Hematologic Indicators in Patient Under Intensive Care for COVID-19 Disease: A One-Year Study at a Tertiary Care Centre in South India.
Balasubramanian J; Suman FR; Stephen IR; Shanmugam SG; Mani R; Mathan B; P L
Cureus; 2021 Nov; 13(11):e19585. PubMed ID: 34926056
[TBL] [Abstract][Full Text] [Related]
14. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters.
Wang C; Deng R; Gou L; Fu Z; Zhang X; Shao F; Wang G; Fu W; Xiao J; Ding X; Li T; Xiao X; Li C
Ann Transl Med; 2020 May; 8(9):593. PubMed ID: 32566620
[TBL] [Abstract][Full Text] [Related]
15. [Biochemical analysis between common type and critical type of COVID-19 and clinical value of neutrophil/lymphocyte ratio].
Li H; Zhao M; Xu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):965-971. PubMed ID: 32895161
[TBL] [Abstract][Full Text] [Related]
16. The Role of De Ritis Ratio as a Clinical Prognostic Parameter in COVID 19 Patients.
Guzey-Aras Y; Yazar H; Acar T; Kayacan Y; Acar BA; Boncuk S; Eryilmaz HA
Clin Lab; 2021 Oct; 67(10):. PubMed ID: 34655209
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil to lymphocyte ratio and C-reactive protein level as prognostic markers in mild versus severe COVID-19 patients.
Mousavi-Nasab SD; Mardani R; Nasr Azadani H; Zali F; Ahmadi Vasmehjani A; Sabeti S; Alavi Darazam I; Ahmadi N
Gastroenterol Hepatol Bed Bench; 2020; 13(4):361-366. PubMed ID: 33244379
[TBL] [Abstract][Full Text] [Related]
18. Hematologic Profiles and Correlation Between Absolute Lymphocyte Count and Neutrophil/Lymphocyte Ratio with Markers of Inflammation of COVID-19 in an Indonesian National Referral Hospital.
Sukrisman L; Sinto R; Priantono D
Int J Gen Med; 2021; 14():6919-6924. PubMed ID: 34703296
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of inflammatory markers in patients with COVID-19 in Indonesia.
Prasetya IB; Cucunawangsih ; Lorens JO; Sungono V; El-Khobar KE; Wijaya RS
Clin Epidemiol Glob Health; 2021; 11():100803. PubMed ID: 34124411
[TBL] [Abstract][Full Text] [Related]
20. Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality.
Vafadar Moradi E; Teimouri A; Rezaee R; Morovatdar N; Foroughian M; Layegh P; Rezvani Kakhki B; Ahmadi Koupaei SR; Ghorani V
Am J Emerg Med; 2021 Feb; 40():11-14. PubMed ID: 33333477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
